Quick Answer

If you already have a list of Seed & Series A CTOs in medtech and insurtech (built using Origami), you’re ready to launch a LinkedIn outreach campaign entirely from inside Origami. Origami has a built-in LinkedIn sequencer that sends connection requests, follow‑up messages, and tracks replies – no exporting CSVs or jumping between tools. Below, I’ll walk you through refining your list, setting up a 3‑touch sequence with actual copy you can steal, and sending it with expectations on results.

Introduction: You’ve Got the List – Now Make It Work

In the how to build a list of Seed & Series A CTOs in Medtech and Insurtech guide, you used Origami to describe your ideal customer in plain English and instantly get a targeted prospect list with verified names, emails, phone numbers, and enriched company details. That list is your raw material. But a list without action is just a spreadsheet.

This companion guide covers the outreach layer: turning those names into conversations. I’ll assume you’ve already built your prospect list inside Origami (if not, grab it on the free plan – 1,000 credits, no credit card required). Now we’ll refine it for LinkedIn, craft a sequence so specific that Seed/Series A CTOs in regulated sectors will actually respond, and send it all from the same platform.

Let’s get tactical.

Step 1: Refine & Segment Your List for LinkedIn

Before you fire off any messages, you need to trim the fat and group leads in a way that keeps your sequences relevant. Origami’s enriched profiles make this fast.

What to remove

Wrong funding stage: If Origami pulled someone at a Seed company but you later notice they’ve grown to Series B or beyond (check “Funding Round” and employee count), cut them. A Series B CTO has different headaches.
Non‑CTO titles: You asked for CTOs, but sometimes VPs of Engineering or Co‑founders without a tech‑leadership title slip in. If their day‑to‑day isn’t making architecture, compliance, and engineering hiring decisions, remove them.
Inactive profiles: Low LinkedIn activity (no posts in 6 months) might mean they’re not checking DMs. Origami often enriches with social activity signals; use that to deprioritize dormant profiles.
Wrong industry: Medtech and insurtech companies sometimes list themselves broadly as “Healthcare” or “Financial Services.” Double‑check descriptions. If they’re not building regulated software or devices, they’ll fight your messaging.

How to segment

Within your remaining list, create two segments inside Origami:

Medtech (companies building medical devices, digital health platforms, diagnostics, or hospital SaaS)
Insurtech (companies building underwriting platforms, claims automation, embedded insurance, or actuarial/data products)

Why? The pain points are similar – regulation, data security, scaling engineering under constraints – but the language you use changes. You’ll reference HIPAA/FDA for medtech, and NAIC/compliance or legacy systems for insurtech. Even a one‑word shift can double reply rates.

You can also segment by company size (1–10 employees vs. 20–50) because a 3‑person CTO is still hands‑on coding while a 40‑person CTO spends more time on hiring and platform architecture.

What “qualified” looks like for this audience

A truly qualified Seed/Series A CTO in medtech or insurtech has at least three of these signals, all visible inside Origami’s enriched contact card:

Raised a Seed or Series A round in the last 12–18 months
Hiring for senior engineering, DevOps, or compliance roles
Mentions modernization (cloud migration, microservices, API‑first) in their blog or tech stack
Active in regulatory discussions (FDA submissions, SOC2, HITRUST, state insurance filings)
Has a technical challenge that maps to what you’re selling – e.g., building real‑time data pipelines or secure APIs for partners

Segment your list now. The next step assumes you’ve grouped them and are ready to send different sequences to medtech vs. insurtech (if the nuance warrants it).

Step 2: Create Your 3‑Touch LinkedIn Sequence

In Origami, you have two paths to create your outreach sequence:

Paste your own templates – Write a 3‑touch sequence yourself (connection request note + two follow‑ups), set the delays between touches (e.g., Day 1, Day 3, Day 7), and Origami will send them automatically. You can use personalization tokens like , , `` that draw from the enriched profile. This path gives you full control over tone and copy.
Let the AI agent write it – Alternatively, you can ask Origami’s AI agent to generate a personalized 3‑day sequence for all your leads. It writes each message based on each lead’s actual profile data: title, company, tech stack, recent funding, and industry. The output feels custom – one lead might get a reference to their latest FDA clearance, another to their recent insurtech partnership. You can review and tweak before launching.

I’ll give you copy for path #1 below because that’s what you came for. Use it as a starting point, then let Origami’s tokens and AI scale the personalization.

The Sequence Structure

All messages are sent as LinkedIn connection request notes (for the first touch) or InMail/messages (if already connected). We’ll avoid InMail for touch 2 and 3 if you’re not connected, because most CTOs at this stage accept connection requests from relevant people. The cadence: Day 1 (connection request), Day 3 (follow‑up message), Day 7 (final message). Adjust delays if you want a slower cadence – just remember these are busy people.

Sequence Copy – Medtech & Insurtech (use the appropriate variant)

I’ve written two variants: one tweaked for medtech, one for insurtech. They reference real pain points: scaling proprietary algorithms while staying compliant, shrinking “time to submission,” dealing with legacy insurer APIs, and building engineering teams that understand both code and regulation. All messages are 60–90 words, direct, and free of fluff.

Variant A: Medtech

Day 1 – Connection request note (300 char max; this is ~280)

, saw your recent Series A – impressive traction building . As you scale, I’m curious how you’re balancing FDA/CE‑mark requirements with engineering velocity. Would love to connect and swap notes.`
Day 3 – Follow‑up message (after connection accepted)

Hey – thanks for connecting. I talk to a lot of Seed/Series A CTOs in medtech who are wrestling with optimizing software‑as‑a‑medical‑device (SaMD) pipelines while keeping design history files audit‑ready. Many tell me the bottleneck isn’t coding – it’s manual compliance checks that eat 20% of sprints. Curious if that resonates with what you’re building at.`
Day 7 – Final message (soft close)

``, one last note. I’ve helped medtech CTOs cut regulatory overhead by automating parts of their 510(k) or PMA software documentation, freeing up senior engineers for architecture work. If scaling safely and faster is a priority right now, I’d be happy to share a 15‑minute walkthrough of how we do it. No pitch, just tactics.`

Variant B: Insurtech

Day 1 – Connection request note

``, your recent Seed round caught my eye – insurtech is finally breaking through legacy lock‑in. Curious how you’re approaching the engineering side: building real‑time data pipelines that play nice with carrier APIs without violating state regs. Let’s connect.`
Day 3 – Follow‑up message

Hey , thanks for connecting. I speak with early‑stage insurtech CTOs daily, and a recurring theme is the pain of ingesting messy actuarial data from 30‑year‑old mainframes while keeping SOC2 and NAIC model audit rules happy. Most end up overbuilding internal tools. If that’s a challenge at , I’d love to hear how you’re tackling it.`
Day 7 – Final message

``, last ping from me. I’ve been working with insurtech teams to shorten the time from carrier data ingest to underwriter‑ready analytics – all while maintaining the compliance paper trail. If that’s on your roadmap, I can show you how we do it in 15 minutes. No strings, just lessons learned.`

Important: These messages assume you’re selling a technical solution that relates to compliance automation, data pipeline tooling, or engineering velocity in regulated environments. If your product is different, adjust the pain point references (e.g., replace “compliance checks” with “product‑market fit experiments” or “attracting technical talent”). The structure – problem recognition, shared challenge, soft offer – remains the same.

How to load these templates into Origami

Inside your Origami campaign, click Sequence, then Paste Template.
For each touch, paste the message (with tokens) into the editor.
Set delay: Day 1 for the connection note, Day 3 for touch two, Day 7 for touch three.
Choose the lead segment (Medtech or Insurtech) you want to apply it to.
Save draft and preview a few leads to see the personalization render.

If you prefer the AI‑generator route, simply describe your value prop to Origami’s agent: “Write a 3‑touch LinkedIn sequence for Seed/Series A medtech CTOs. Mention regulatory bottlenecks, SaMD pipelines, and share a 15‑min call idea.” It will produce a batch of tailored messages. Review and approve, then launch.

Step 3: Send the Sequence Directly from Origami

This is where Origami separates itself from list‑building tools that stop at the CSV export. You can launch the entire LinkedIn outreach without leaving the platform.

How sending works

The built‑in LinkedIn sequencer sends connection requests automatically (you must have your LinkedIn account connected).
Once a request is accepted, it waits the delay you set, then drops the follow‑up message – either as a direct message or, if you prefer, an InMail (though direct messages feel more natural after connecting).
If a lead replies at any point – even a simple “Not interested” – they are automatically un‑enrolled from the rest of the sequence. No accidental breakup emails after a booked meeting.
All actions appear in a unified dashboard: connection requests sent, accepts, replies, and link clicks (if you added a URL).

Tracking and context

While you’re watching a lead’s activity in the campaign view, you can still see their full enriched profile on the same screen: title, company size, funding, tech stack, tools used, recent news. So when someone replies “Tell me more,” you immediately know why you reached out to them and can tailor your live response – no switching tabs.

No extra cost for the sequencer

Origami’s LinkedIn sequencer is included on all paid plans at no extra charge. You only pay for the credits used to enrich your leads. Paid plans start at $29/month. Even the free plan (1,000 credits, no credit card) lets you test list building and sequencing with a small batch.

What response rates to expect

For Seed/Series A CTOs in medtech and insurtech, a well‑targeted list with a tight sequence typically yields:

Connection acceptance: 25–35% (higher than generic audiences because your note mentions their funding or relevant challenge)
Reply rate: 8–15% (including positive and negative replies)
Meeting booked rate: 2–5% of all contacted if your offer is relevant

These aren’t guarantees; they depend on your product, the pain point you address, and how well you refine the list. If after 100 sends your connection rate is below 20%, the problem is usually list quality (titles, company stage, industry mismatch). If connection rate is good but replies are under 5%, iterate on the messaging – likely the Day 1 note doesn’t trigger enough curiosity.

When to iterate on messaging vs. the list

Low connect rate (<20%): Your list may have too many irrelevant prospects. Go back to Step 1 and tighten the criteria (only Seed/Series A, only genuine CTOs, only companies with recent funding). Also check your connection note – it should be less than 300 characters and name a specific trigger.
High connect, low reply (>30% connect, <5% reply): Your Day 3 message is too generic, or you’re not referencing a concrete pain point. Try swapping one sentence to mention an industry‑specific challenge (e.g., “time to 510(k) clearance” instead of “compliance”). Test the AI‑generated version alongside your manual template.
Replies but poor conversion to meetings: The soft close on Day 7 might be too soft, or you’re offering a demo instead of a conversation. Make it about shared insights, not a pitch.

Remember: in 2026, Seed/Series A CTOs in regulated sectors are bombarded with generic “scale your engineering” pitches. Your edge is specificity.

Rotate Your Device

How to Run a LinkedIn Outreach Campaign to Seed & Series A CTOs in Medtech and Insurtech (2026 Edition)